The opioid epidemic impacts every community, and pharmacists can be part of the solution.

Opioid Use Disorder Education Program

CPNP’s 17-session OUD Education Program is designed to be part of the solution in addressing this public opioid health crisis by educating pharmacists on how to identify patients with OUD, when to refer untreated patients to providers for treatment, how to develop/recommend evidence‐based treatment plans for OUD, and the steps to monitoring prescribed treatments.

Opioid Use Disorders: Interventions for Community Pharmacists

CPNP is pleased to provide this guideline document intended to educate community pharmacists on interventions they can employ to provide safe and appropriate access to opioids while also protecting the public from the hazards of misuse and abuse. This publication is supported by the American Academy of Addiction Psychiatry under its prime grant from the Substance Abuse and Mental Health Services Administration.

Pharmacist Toolkit: Medication Management of Opioid Use Disorder

Self-reported opioid misuse within the past year was documented in approximately 11.5 million people over the age of 12 who participated in the 2016 National Survey on Drug Use and Health. Over 2 million self-reported a diagnosis of opioid use disorder. It has been documented that approximately 1.8 million Americans have opioid use disorder related to opioid prescriptions. About 626,000 have heroin-related opioid use disorder.

Naloxone Access: A Practical Guideline for Pharmacists

Drug overdoses are occurring at an alarming rate in the United States. Most overdoses have been linked to opioid analgesics, which may have been obtained from community pharmacies. One potential solution is to offer take-home naloxone.